Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-08

Clinical Trial Update: A Trial on Supervised Primaquine Use in Ethiopia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating supervised primaquine use for malaria in Ethiopia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primaquine (primaquine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Malaria | Phase 4 | Status: WITHDRAWN